Wounsol Ointment is a topical formulation combining Ornidazole (1% w/w), Povidone Iodine (5% w/w), and Sucralfate (7% w/w) designed for the management of infected wounds and ulcers. Ornidazole, a nitroimidazole derivative, exhibits potent antiprotozoal and antibacterial activity against anaerobic bacteria, thereby reducing microbial load and preventing infection progression. Povidone Iodine serves as a broad-spectrum antiseptic agent effective against bacteria, fungi, viruses, and protozoa, facilitating rapid microbial eradication and minimizing the risk of secondary infections. Sucralfate acts as a cytoprotective agent promoting wound healing by forming a protective barrier over the ulcerated or damaged tissue, enhancing epithelial regeneration, and stimulating local growth factors. The synergistic combination in Wounsol Ointment ensures comprehensive antimicrobial coverage while supporting tissue repair and reducing inflammation, making it suitable for the treatment of chronic wounds, diabetic ulcers, pressure sores, and post-surgical wounds. The ointment should be applied topically to the affected area once or twice daily after proper wound cleaning, with care taken to avoid contact with eyes and mucous membranes. Wounsol Ointment is contraindicated in patients with known hypersensitivity to any of its components. Regular monitoring and adherence to wound care protocols are recommended to optimize therapeutic outcomes.